Results 61 to 70 of about 13,079 (188)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas

open access: yesFrontiers in Endocrinology, 2019
Dopamine agonists such as bromocriptine and cabergoline are the predominant treatment drugs for prolactinoma by inhibiting prolactin secretion and shrinking tumor size.
Xiaoshuang Liu   +6 more
doaj   +1 more source

Maternal-related factors associated with development and improvement of peripartum cardiomyopathy and therapeutic outcomes of bromocriptine

open access: yesMajalah Obstetri dan Ginekologi
HIGHLIGHTS Younger age, black race, normotension, and multiparity indicate a poorer prognosis for peripartum cardiomyopathy recovery, while bromocriptine therapy reduces adverse events.
I Gusti Bagus Mulia Agung Pradnyaandara   +7 more
doaj   +1 more source

Efficacy and Safety of Bromocriptine-QR as an Adjunctive Therapy on Glycemic Control in Subjects with Uncontrolled Type 2 Diabetes Mellitus

open access: yesJournal of the ASEAN Federation of Endocrine Societies
Introduction. There has been an increasing awareness of the effects of combining bromocriptine-QR with other medications for diabetes mellitus type 2.
Theo Audi Yanto   +3 more
doaj   +1 more source

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

open access: yesJournal of Diabetes Research, 2015
Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk.
Bindu Chamarthi   +7 more
doaj   +1 more source

Herbal medicine in the treatment of hyperprolactinemia patients

open access: yesГинекология, 2013
A comparative analysis of the Cyclodynon (Bionorica SE. Germany) and Bromocriptine (Gedeon Richter) effectiveness in 80 hyperprolactinemia patients has shown that in patients with prolactin levels up to 1000 mIU/L the Cyclodynon clinical efficacy is ...
S D Yavorskaya
doaj  

Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom. [PDF]

open access: bronze, 1993
K Shaw   +28 more
openalex   +1 more source

Home - About - Disclaimer - Privacy